One of my favorite trade setups and success rate is fairly high...
This is a great point of entry, price is above 200MA and MACD signal line below 0 ready to fire! Wait for the cross and load up. A buy signal from TRND will be my confirmation here! Low risk at this area of value setting my stops below support. Load up on the calls!
Trade smart with clean...
Extremely oversold, perfect consolidation for a final run to test the 4.97 resistance. Volume is bottoming off again as well, further confirming that this is the lowest we'll see it.
I need your thoughts on Atossa, I personally think It just broke out of an important pattern and resistance, that it has created since the end of 2017. The targets are around 11,70 and 13,20
This stock has been on my radar and I passed on it when it was cheaper. I have taken a position now and it appears to have made a nice bull-flag on the daily and hourly chart. I have had some good fortune in this sector lately and would encourage others to take a look as well. A realistic S/T target is $3.70 and has the potential to move significantly higher...
Look at those Moving Averages! Things are bound to pick up from here, although anyone who bought in above $2 will still be facing considerable losses for the next few weeks.
ATOS long term graph already set to continue its rise. Additionally, today, Dr. Steven C. Quay, President and CEO, will speak at the 2021 Precision Medicine World Conference “21st Century Precision Medicine in the Age of COVID-19” about “Development of New SARS-CoV-2 Therapeutics.” Get in while you can!
Not much into these, but we've found a floor here, lot's of upside on this company.
Atossa Therapeutics, Inc. develops and markets medical devices, laboratory tests, and therapeutics to address breast health conditions in the United States. The company's lead program is the development of Endoxifen, an active metabolite of tamoxifen which is in Phase II studies...
